Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Women who are pregnant or breastfeeding should not use MOTs-C
The peptide stabilizes cell membranes, supports cellular energy production, and activates protective signaling pathways
Our patients enjoy falling asleep more quickly, staying asleep, and heightened wellness with regular DSIP use
Reported side effects (minimal) Most users report zero side effects - Epithalon remarkably well-tolerated Occasional reported effects: Mild injection site reactions (redness, slight swelling) Temporary headache (first 1-2 days) Slight drowsiness initially (adjusting to improved sleep ) Vivid dreams (from enhanced melatonin ) Increased appetite in some (rare) What Epithalon does NOT typically cause: No nausea (unlike GLP-1 agonists ) No GI upset No hormonal disruption No mood changes (may improve mood) No dependency or withdrawal Side effect comparison: Managing minor side effects: Headache: Hydrate well, usually resolves day 2-3 Drowsiness: Inject at bedtime instead of morning Vivid dreams: Enjoy them or reduce dose slightly Injection reactions : Rotate sites, ice after injection See our peptide safety and risks guide and common peptide mistakes to avoid
Cell-based studies report increased intracellular NAD+ concentration in treated adipocyte cultures
US$ 20.80
US$ 25.64
US$ 26.34
